Skip to main content
Clinical Trials/NCT06207500
NCT06207500
Terminated
Not Applicable

Impact of Routine Pharmacist-led Medication Reconciliation on Medication Discrepancies and Post-hospital Healthcare Utilisation

The University Clinic of Pulmonary and Allergic Diseases Golnik1 site in 1 country553 target enrollmentSeptember 30, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Medication Reconciliation
Sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik
Enrollment
553
Locations
1
Primary Endpoint
Unplanned healthcare utilisation within 30 days after discharge
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

Background:

Transitions of care often lead to medication errors and unnecessary healthcare utilisation. It has been repeatedly shown that medication reconciliation can at least partially reduce this risk.

Objective:

The aim of this prospective pragmatic trial was to evaluate the effectiveness of pharmacist-led medication reconciliation offered to medical patients as part of routine clinical practise.

The main questions to be answered were:

  • the effectiveness of pharmacist-led medication reconciliation on medication discrepancies at discharge and 30 days after discharge
  • the effectiveness of pharmacist-led medication reconciliation on healthcare utilisation within 30 days after discharge.

Participants in the intervention group were offered the following:

  • medication reconciliation on admission
  • medication reconciliation on discharge, coupled with patient counselling, provided by clinical pharmacists.

Participants in the control group were offered standard care.

Detailed Description

Design: pragmatic, prospective, controlled clinical trial Setting: Five general medical wards at the University Clinic of Respiratory and Allergic Diseases in Slovenia: * one intervention ward with a routine pharmacist-led medication reconciliation service * four control wards Data collection: * Data collection and outcome assessment were performed by research pharmacists who were clinical pharmacists or final year clinical pharmacy residents not involved in the treatment of the included patients. * Data for the assessment of medication errors at discharge were obtained from the patients' medical records and the study documentation. * The reason for the patient's hospitalisation was obtained from the discharge letter and divided into acute or planned admissions. The main diagnosis was the reason for admission, while all other patient diagnoses listed were used to assess comorbidity. * Patient comorbidity was assessed using the Charlson Comorbidity Index * For patients in the control group the BPMH was collected in the same way as in the intervention group. However, it was only used for study purposes and was not documented in the patients' medical records * Data on healthcare utilisation and medication discrepancies after hospital discharge were collected through patients or caregivers' phone interview.

Registry
clinicaltrials.gov
Start Date
September 30, 2019
End Date
December 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik
Responsible Party
Principal Investigator
Principal Investigator

Maja Jošt

Clinical Pharmacist

The University Clinic of Pulmonary and Allergic Diseases Golnik

Eligibility Criteria

Inclusion Criteria

  • All adult medical patients admitted to the study wards

Exclusion Criteria

  • patients who do not speak Slovenian,
  • transferred from another ward,
  • previously included in the same study.
  • Subsequent exclusion from the analysis:
  • patients hospitalised only for diagnostic purposes,
  • patients transferred to another ward or hospital,
  • patients that died during hospitalisation,
  • patients from the control group who were offered medication reconciliation

Outcomes

Primary Outcomes

Unplanned healthcare utilisation within 30 days after discharge

Time Frame: within 30 (±5) days after hospital discharge

Unplanned healthcare utilisation within 30 days of hospital discharge was defined as any unplanned visit to a general practitioner, specialist, emergency department (ED), or hospitalisation or death. The visits were classified as unplanned, if sudden health problems required medical attention, and planned, if scheduled. Data on mortality due to any reason were also collected 30 days after discharge. For each patient, only the most detrimental outcome was classified.

Secondary Outcomes

  • Clinically important medication errors at discharge(On the day of hospital discharge (up to 365 days from hospital admission))
  • Serious unplanned healthcare utilisation within 30 days after discharge(within 30 (±5) days after hospital discharge)
  • Medication discrepancies at 30 days(At 30 (±5) days after hospital discharge)
  • All healthcare utilisation within 30 days after discharge(within 30 (±5) days after hospital discharge)

Study Sites (1)

Loading locations...

Similar Trials